< Back to latest news & events

Event

Life Sciences Patent Network Europe 2019

November 2019

Event date: 21st November 2019

HGF Partner Dr Claire Irvine will be hosting a roundtable on Navigating the CRISPR patent and licensing landscape at Life Sciences Patent Network Europe 2019 on 21st November.

CRISPR gene-editing continues to hit the headlines regularly as a ground-breaking technology with many millions now flowing into companies seeking to exploit the technology in both the therapeutic and agricultural fields. Unfortunately, the IP landscape continues to lack clarity with possibility of divergence between Europe and the US.

Oral proceedings for the University of California have been scheduled at the EPO for early February 2020 with the preliminary non-binding opinion of the opposition division favouring the patentees on coverage extending to CRISPR/Cas9 gene-editing in eukaryotic cells.

Join Dr Claire Irvine’s roundtable session, where she will discuss and update you on:

  • The CRISPR IP saga and the interplay between the latest chapter in Europe and the US
  • New interference proceedings instigated by the USPTO
  • Opposition and appeal proceedings affecting key European patents at the European Patent Office
  • The considerations about freedom-to-operate in the absence of resolution of a standard for CRISPR gene-editing for therapy and the growing number of claims outside the main battle lines.

Attendees

Latest updates

Can AI replace patent attorneys?

OpenAI recently released a dialogue-based AI chatbot called ChatGPT, which is free for anyone to try out. You can try it here (https://chat.openai.com/chat). It’s been shown that it can set, …

Read article

HGF office closures in December 2022 and January 2023

Please note that our offices will be closed for business in accordance with national holidays on the following dates. Please plan accordingly and provide us with your instructions in advance …

Read article

Start of the UPC Sunrise Period delayed to 1 March 2023

The UPC sunrise period which was expected to start on 1 January 2023 has now been postponed to 1 March 2023. Consequently, the entry into force of the UPCA and …

Read article

Gender diversity at the UPC

In Europe, women remain grossly under-represented in research and innovation. A recent study by the European Patent Office (EPO) found that only 13.2% of inventors in Europe are women. The …

Read article
Event - 29th November 2022

LSPN Europe 2022

HGF is a silver sponsor of LSPN Europe 2022 on 29th November in London. This event will explore some of the biggest challenges facing the Life Sciences Patent Community right now …

Event details

Oral Proceedings by videoconference (VICO) in oppositions proceedings to become permanent

The pilot project for oral proceedings in opposition proceedings by video conference (VICO) started during the pandemic and has received positive feedback.[1] The President of the EPO has therefore declared …

Read article